Akdital (CAS:AKT) Marketable Securities: MAD602 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAS:AKT Akdital CAS:AKT
84 GF Score
Price MAD1,132.00
GF Value MAD2,174.22
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Akdital Marketable Securities?

Akdital CAS:AKT -0.35% 84 Marketable Securities is MAD602 Mil as of Dec. 2025. GuruFocus rates CAS:AKT with a GF Score™ of 84/100 and a GF Value™ of MAD2,174.22 (Possible Value Trap). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Akdital's Marketable Securities for the quarter that ended in Dec. 2025 was MAD602 Mil.

Akdital's annual Marketable Securities increased from Dec. 2023 (MAD0 Mil) to Dec. 2024 (MAD323 Mil) and increased from Dec. 2024 (MAD323 Mil) to Dec. 2025 (MAD602 Mil).

Akdital  (CAS:AKT) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Akdital Marketable Securities Related Terms

Akdital Marketable Securities Historical Data

* Premium members only.

The historical data trend for Akdital's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akdital Marketable Securities Chart

Akdital Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.01 322.53 601.78

Akdital Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 322.53 110.53 601.78
CAS:AKT
84GF Score
Akdital CAS:AKT
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akdital Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of MAD602 Mil mean?
Akdital (CAS:AKT) has a Marketable Securities of MAD602 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Akdital and its competitors.
Is Akdital's Marketable Securities too high?
Akdital's current Marketable Securities is MAD602 Mil. Overall, Akdital has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akdital's Marketable Securities compare to HCA and THC?
Akdital's Marketable Securities of MAD602 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Akdital and its competitors. Akdital's current Marketable Securities is MAD602 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akdital stock overvalued right now?
Based on GuruFocus' analysis, Akdital (CAS:AKT) is currently considered Possible Value Trap. The stock's GF Value™ is MAD2,174.22, compared to a current price of MAD1,132.00 — trading 47.9% below its estimated fair value. The current Marketable Securities is MAD602 Mil. Akdital's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Akdital (CAS:AKT), the current Marketable Securities is MAD602 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Akdital (CAS:AKT) Overvalued in 2026?

Based on GuruFocus' analysis, Akdital stock appears to be undervalued. The current stock price of MAD1,132.00 is trading 47.9% below its estimated GF Value™ of MAD2,174.22. GuruFocus considers Akdital to be Possible Value Trap.

Key valuation signals for CAS:AKT:

  • Marketable Securities: MAD602 Mil
  • GF Value™: MAD2,174.22 vs. price of MAD1,132.00 (47.9% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the CAS:AKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Akdital Business Description

Address 246 Route de l’Oasis, Casablanca, MAR, 20250
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
84GF Score

Get the complete analysis for CAS:AKT

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD1,132.00
Price
MAD2,174.22
GF Value